Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids.
about
Cytotoxic proteins and therapeutic targets in severe cutaneous adverse reactionsToxic epidermal necrolysis in acquired immunodeficiency syndrome treated with intravenous gammaglobulin.Toxic epidermal necrolysis following treatment of pseudotumour cerebri: a case reportMucocutaneous disorders.Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and Treatment With a Biologic: A Case Report.Treatment of severe drug eruptions.Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.Toxic epidermal necrolysis: a burn-centre challenge.Trimethoprim/sulfamethoxazole-induced toxic epidermal necrolysis.Stevens-Johnson Syndrome and toxic epidermal necrolysis: a multi-aspect comparative 7-year study from the People's Republic of ChinaInterventions for toxic epidermal necrolysis.Severe bullous skin diseases: analysis of seven children managed in a burns unit.Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand.High-dose intravenous immunoglobulin in the treatment of toxic epidermal necrolysis: a study of ocular benefits.Topical clobetasol for the treatment of toxic epidermal necrolysis: study protocol for a randomized controlled trialToxic epidermal necrolysis (TEN) Lyell's syndrome.Patients with acute skin loss: are they best managed on a burns unit?Toxic epidermal necrolysis/Stevens-Johnson syndrome: current trends in management.Stevens-Johnson syndrome: pathogenesis, diagnosis, and management.Management of burn injuries--recent developments in resuscitation, infection control and outcomes research.Drug induced toxic epidermal necrolysis: two case reports.Immune mediation of hypersensitivity adverse drug reactions: implications for therapy.Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of the experience with paediatric patients in a university hospital.Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options.Immune reactions to drugs and diagnostic agents.Stevens Johnson syndrome in association with Mycoplasma pneumonia.Stevens Johnson syndrome after carbamazepine and SJS/TEN overlap syndrome after amoxicillin: case reports and a review.The management of toxic epidermal necrolysis.Toxic epidermal necrolysis: performance of SCORTEN and the score-based comparison of the efficacy of corticosteroid therapy and intravenous immunoglobulin combined therapy in China.Mesenteric ischemia secondary to toxic epidermal necrolysis: case report and review of the literature.Immunologic Mediators in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.Two unusual cases of toxic epidermal necrolysis.Reversal of erythema multiforme major with cyclophosphamide and prednisone.Paracetamol induced Stevens-Johnson syndrome--toxic epidermal necrolysis overlap syndrome.Spectrum of anticonvulsant hypersensitivity syndrome: controversy of treatment.Toxic epidermal necrolysis associated with acetaminophen ingestion.Head and neck manifestations of erythema multiforme in children.Epidemiology and costs of patients with toxic epidermal necrolysis: a 27-year retrospective study.Incidence, causative drugs, and economic consequences of drug-induced SJS, TEN, and SJS-TEN overlap and potential drug-drug interactions during treatment: a retrospective analysis at an Indonesian referral hospital.Toxic Epidermal Necrolysis : A Case Report.
P2860
Q28395744-6C5DBC33-7EEC-42D2-83BC-CE9A0E65FB4CQ30752612-504CA4FF-E660-4C0C-BD02-CEDEA3F7119AQ33587297-D18F1866-248F-4A43-8473-E999B5F66801Q33592379-C05AD62E-FA31-4FD5-B9B1-21B05072DF56Q33655940-D7767B8F-31F9-4F07-8212-5440EC13DF13Q33817874-5D8418D6-EE37-4264-B880-1A61E191962DQ33844415-AFD47A19-3EF9-4B7B-AD5F-08F1AB5A9427Q34273531-A451320D-AD33-45B1-8306-EB3EBBA1649FQ34284252-9B8C52C5-5F3E-4359-8949-9E0E6E7826D2Q34742870-14B45A52-B4EB-4F42-88A6-97813F75E307Q35041791-2A37A177-E944-4B63-8C47-7918C7C4059CQ35279989-FA21D355-AE9D-4ADD-955D-3D9DD8C158ABQ35749162-8DF09534-4080-4D8F-8058-F01D2B9D526CQ35897124-7A749623-7830-45BD-91FF-C425D646EAABQ35987000-931C3D54-FCEE-46B4-8317-52895F94EE08Q36374575-A895743E-3244-4180-8D0E-73A7AFBAFF5DQ36822742-CC12D6F4-2E13-4DBC-A475-8E9B50C66259Q36884071-A280C3C5-0872-4BE0-B483-1A0BA1A54D8EQ37091877-8AF2F436-8D88-49CE-A220-84E51AABEF28Q37152935-50B4C2A8-9286-4A5E-8E1A-A372AA77CF93Q37403485-A48D7DE1-7B5C-4C57-9127-79EA4BFB829EQ37510953-ACC5F4C6-52BC-4F8E-BC52-AB2F9E86020AQ37825557-22E49B1D-AFF4-4B20-B471-2367AAE1FBC1Q37853599-4D1F0474-0B2A-4BB1-A644-28720C703E3DQ37931143-7D427340-7D7D-433E-9A2C-CD65BEF0C930Q37947464-3CF09ECD-5945-42FC-B452-FD49D6F6F585Q37988852-D482BD34-204A-43B8-8E83-2719CBF674AEQ38033613-730CC86E-7AB8-455E-A4F0-775EB6A9D36DQ38041396-8B1F14DA-8959-419B-98FB-0A74BF3DA1ACQ38185261-C3418B41-D5AB-418C-AA9E-7663F71C6DDFQ38766822-5741C6CB-83D8-4B54-9529-EE2A91431EAAQ39122680-59FA2A5C-5780-45D8-B318-4A7A5DA1C879Q39464719-73E19DD0-2534-44A4-800E-65C2183FF117Q40212817-F114B7C9-4D10-4360-BA7F-2A3C3F12F48AQ40518881-0F6EA041-61CC-4AFC-8DC3-73F690B1EBDAQ40626460-7431EF0B-9C41-4D02-988F-7255FF1DFBBEQ40701892-3BD02862-6657-4570-93B5-55F3124B9AEBQ41293986-AE5CA660-CF0A-4411-8D31-78787CAEC8A0Q42339143-72DD6F33-2705-4406-9463-1B7180B8B35AQ42532816-14908BA6-490D-40C4-BB06-EFBE5A566232
P2860
Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids.
description
1986 nî lūn-bûn
@nan
1986 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Improved burn center survival ...... naged without corticosteroids.
@ast
Improved burn center survival ...... naged without corticosteroids.
@en
Improved burn center survival ...... naged without corticosteroids.
@nl
type
label
Improved burn center survival ...... naged without corticosteroids.
@ast
Improved burn center survival ...... naged without corticosteroids.
@en
Improved burn center survival ...... naged without corticosteroids.
@nl
prefLabel
Improved burn center survival ...... naged without corticosteroids.
@ast
Improved burn center survival ...... naged without corticosteroids.
@en
Improved burn center survival ...... naged without corticosteroids.
@nl
P2093
P1433
P1476
Improved burn center survival ...... naged without corticosteroids.
@en
P2093
Finklestein JL
Halebian PH
P304
P356
10.1097/00000658-198611000-00001
P407
P577
1986-11-01T00:00:00Z